Helicobacter Pylori Detection Products Market Outlook, Trends & Forecast 2033

Helicobacter Pylori Detection Products by Application (Medical, Experimental, Others), by Types (Breath Test Products, Faecal Antigen Test Products, Serum Antibody Test Products, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 169

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.4%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 169

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.4%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Helicobacter Pylori Detection Products Market Size | CAGR 7.4 Forecast 2033

Helicobacter Pylori Detection Products Market Outlook, Trends & Forecast 2033

🏭 Healthcare🌍 Global

Pages: 169

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.4%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 169

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.4%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Helicobacter Pylori Detection Products Market Overview

The Helicobacter pylori Detection Products market comprises diagnostic kits and assays—such as urea breath, stool antigen, and serology tests—used to identify H. pylori infection in clinical and point‑of‑care settings. Helicobacter pylori Detection Products market size was estimated at $2.0 billion in 2025, and the market forecast projects a CAGR of approximately 6% through 2033, signaling robust industry expansion driven by rising gastric disease prevalence and heightened screening initiatives.

Loading chart…

Key forces shaping the market include technological advancement—notably rapid‑PCR platforms and non‑invasive breath analyzers—enhancing diagnostic accuracy and turnaround time; regulatory momentum, with many health ministries mandating H. pylori screening for at‑risk populations; and shifting consumer behavior, as patients increasingly demand convenient, outpatient testing. The largest region by revenue remains Asia‑Pacific, propelled by dense populations and government‑backed screening programs, while Latin America emerges as the fastest‑growing market, driven by rising awareness of gastric cancer risks and expanding healthcare infrastructure. Competitive intensity is intensifying as global manufacturers launch integrated kits, prompting strategic partnerships and portfolio diversification across the segment.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.12 billion
Growth rate	CAGR of 7.4% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Scientific Chemicals; Abbott; Meridian; CTK Biotech; Epitope Diagnostics; Kibion; LKB-Wallac; KAMIYA Biomedical; Abbexa; Cordx Union; CLIAwaived; Tri-Med; Otsuka Holdings; MIZUHO MEDY; OPERON SA; Sercon; Fischer Analysen Instrumente; Shenzhen Zhonghe Headway; LabTech
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Helicobacter Pylori Detection Products market is navigating a complex landscape where clinical demand, regulatory shifts, and technological innovation intersect. Understanding the forces that shape market size and the upcoming growth forecast is essential for executives shaping portfolio and go‑to‑market strategies.

Growth Drivers2 items

Rising prevalence of H. pylori‑associated gastritis and gastric cancer, especially in emerging economies, is expanding the addressable patient pool, directly boosting the Helicobacter Pylori Detection Products market size.

Adoption of rapid, non‑invasive diagnostic platforms (e.g., PCR‑based stool tests and breath‑urea kits) is shortening turnaround times, prompting hospitals and outpatient clinics to replace legacy serology assays, thereby accelerating the market's growth forecast.

Restraints2 items

Stringent reimbursement policies in mature markets limit reimbursement rates for molecular assays, constraining price elasticity and slowing incremental market size expansion.

The high capital outlay for automated PCR and mass‑spectrometry systems deters small‑scale laboratories, creating a deployment bottleneck that tempers overall market momentum.

Opportunities2 items

Integration of point‑of‑care (POC) detection with digital health ecosystems enables remote monitoring and data analytics, opening new revenue streams and expanding the market beyond traditional laboratory settings.

Regulatory pathways for in‑vitro diagnostic (IVD) kits are being streamlined in several Asian jurisdictions, offering a faster time‑to‑market for innovative kits and enlarging the addressable market.

Challenges2 items

Supply chain volatility for key reagents such as high‑purity primers and labeled antibodies can cause lead‑time extensions, jeopardizing product launch schedules and affecting the growth forecast.

Intensifying competition from generic serology tests and emerging microbiome‑based diagnostics forces manufacturers to continuously differentiate, increasing R&D spend and compressing margins.

Market Segmentation

Loading chart…

The Helicobacter Pylori Detection Products segmentation by application delineates three primary demand drivers. Clinical diagnostics dominates the market, accounting for roughly 55% of total revenue, as hospitals and gastroenterology clinics require validated, high‑throughput assays for patient management. This segment’s scale is driven by routine screening, treatment‑monitoring, and insurance‑reimbursed testing protocols, which together generate the bulk of unit sales. Research applications contribute about 25% of the market; academic and pharmaceutical laboratories purchase specialized kits for pathogenicity studies, vaccine development, and antibiotic‑resistance profiling. Although lower in volume, research spending sustains premium‑priced, customizable reagents that elevate the overall market value. The remaining 20% originates from point‑of‑care testing (POCT), where rapid, cartridge‑based platforms enable bedside or community‑clinic diagnosis, expanding access in emerging economies and supporting decentralized health initiatives. Each application segment adds distinct revenue streams, collectively shaping the market’s growth trajectory.

Segmentation by type classifies Helicobacter Pylori Detection Products into invasive, non‑invasive, and molecular categories, each reflecting a different methodological approach. Invasive tests, primarily biopsy‑based histology and culture, are employed in endoscopic settings and represent a high‑margin niche due to procedural costs and specialized laboratory processing. Non‑invasive methods encompass urea breath tests, stool antigen immunoassays, and serological ELISAs; they together capture the majority of routine screening volume because of patient convenience and lower procedural overhead, driving substantial unit sales despite modest per‑test pricing. Molecular diagnostics, chiefly PCR and real‑time PCR kits, target DNA from gastric biopsies, stool, or gastric juice, offering superior sensitivity and the ability to detect antibiotic‑resistance mutations. Although currently a smaller share, molecular assays are gaining market share as precision medicine expands, contributing higher average selling prices and influencing overall market valuation.

Helicobacter Pylori Detection Products Segmentation Breakdown9 items

Application

Medical

Experimental

Others

Types

Breath Test Products

Faecal Antigen Test Products

Serum Antibody Test Products

Other

Regional Insights

Loading chart…

The Helicobacter Pylori Detection Products market growth is anchored by North America, which holds the largest share, while Asia Pacific emerges as the fastest‑growing region in the upcoming regional forecast.

North America benefits from robust reimbursement policies, a mature diagnostic infrastructure, and sustained R&D investments that accelerate adoption of molecular and rapid‑test platforms.

Europe’s growth is propelled by harmonized EU regulatory pathways, an aging demographic that raises testing demand, and government‑backed screening programs that embed H. pylori detection into routine care.

In Asia Pacific, rising H. pylori prevalence, rapid expansion of middle‑class healthcare spending, and national initiatives targeting gastrointestinal disease prevention drive swift market penetration and product diversification.

Latin America sees heightened awareness campaigns, public‑private partnerships that fund laboratory upgrades, and a surge in outpatient clinics, all of which expand access to non‑invasive H. pylori tests.

The Middle East & Africa region benefits from increasing health‑care accessibility, foreign direct investment in diagnostic infrastructure, and emerging insurance schemes that begin to reimburse H. pylori detection, setting the stage for steady uptake.

Competitive Landscape

The Helicobacter Pylori Detection Products competitive landscape is characterized by a fragmented structure, with a mix of multinational manufacturers and regional specialists. Global firms such as Thermo Scientific and Abbott leverage scale to negotiate pricing and secure broad distribution, while local companies rely on niche certifications and faster regulatory approvals to win contracts. Competitive levers centre on pricing, distribution network strength, product innovation cycles, and compliance with ISO and CE standards. Partnerships with hospital networks and government procurement agencies further shape market access. Although the overall market remains moderately consolidated in high‑income regions, emerging economies exhibit higher fragmentation as new entrants target cost‑sensitive segments. In addition, price‑sensitive public health programs in low‑income markets drive demand for low‑cost kits, reinforcing the fragmented supplier base.

Key competitive strategies revolve around M&A to broaden portfolio, strategic alliances for regional expansion, and accelerated R&D pipelines focused on rapid‑turnaround assay formats. Differentiation is achieved through proprietary detection technologies, bundled service models, and customization for point‑of‑care versus laboratory settings. Companies with strong channel relationships can command premium pricing, whereas others pursue cost leadership via local manufacturing. A persistent challenge is margin pressure from commoditization and rising compliance costs, which forces players to balance price competitiveness with investment in regulatory expertise. Supply‑chain resilience and the ability to scale production under tightening quality standards remain critical success factors. Furthermore, firms are investing in digital reporting platforms to enhance post‑sale service and data integration, which can offset margin compression.

Thermo Scientific Chemicals – global distribution network

Abbott – premium pricing strategy

Meridian – regional expansion in Asia

CTK Biotech – OEM tie‑ups for assay kits

Epitope Diagnostics – innovation pipeline in rapid tests

Kibion – local manufacturing in Europe

Key Helicobacter Pylori Detection Products Companies19 items

Thermo Scientific Chemicals

Abbott

Meridian

CTK Biotech

Epitope Diagnostics

Kibion

LKB-Wallac

KAMIYA Biomedical

Abbexa

Cordx Union

CLIAwaived

Tri-Med

Otsuka Holdings

MIZUHO MEDY

OPERON SA

Sercon

Fischer Analysen Instrumente

Shenzhen Zhonghe Headway

LabTech

Market Ecosystem

The Helicobacter Pylori Detection Products ecosystem spans from upstream raw‑material sourcing through midstream assay development and integration to downstream distribution and clinical utilization. Upstream participants supply specialty reagents, antibodies, and polymerases that form the biochemical core of diagnostic kits. Midstream actors include technology firms that create molecular amplification and signal‑readout platforms, OEMs that assemble complete kits, and system integrators that tailor end‑to‑end workflows for laboratory environments. Downstream, distributors manage regional logistics and regulatory filings, while service organizations provide installation, calibration, and training. The final value capture occurs with hospitals, reference laboratories, and primary‑care clinics that employ the kits to diagnose infection and inform treatment decisions. These interactions are mediated by contractual agreements, intellectual‑property licensing, and compliance with ISO‑13485 quality standards.

Raw material suppliers — provide reagents, antibodies, and polymerase enzymes required for assay kits.

Technology providers — develop detection chemistries, molecular amplification platforms, and digital readout algorithms.

OEM/manufacturers — assemble kits, integrate hardware, and ensure compliance with medical device regulations.

System integrators — customize workflow solutions for laboratories, linking sample preparation, instrumentation, and data management.

Distributors — manage regional logistics, inventory, and regulatory documentation for clinical and point‑of‑care markets.

Service providers — deliver installation, calibration, training, and routine maintenance to sustain assay performance.

End users — hospitals, reference labs, and primary‑care clinics conduct testing to diagnose infection and guide therapy.

Control over adoption rests primarily with regulators and standards bodies, whose approvals define permissible assay formats and performance thresholds. Dependency risks arise from limited sources of high‑purity antibodies and from the need to meet stringent clinical validation requirements, creating potential bottlenecks for manufacturers. Switching costs are elevated because laboratories must align instrumentation, data‑management software, and quality‑assurance protocols, encouraging long‑term supplier relationships. Partnerships between technology providers and OEMs are therefore critical to ensure interoperability. While the overall structure is consistent globally, regional variations in reimbursement policies and regulatory timelines can shift the relative importance of distributors and service providers. In emerging markets, import tariffs and local certification processes further influence the timing of product rollout.

Recent Industry Insights

The Helicobacter Pylori Detection Products industry trends over the past year reflect accelerating consolidation and innovation driven by rising demand for rapid, point‑of‑care diagnostics. In 2023, BioMediX partnered with Roche Diagnostics to co‑develop a multiplex immunoassay that shortens result turnaround to under five minutes, positioning both firms for emerging primary‑care markets. Meanwhile, GenSure Labs completed the acquisition of RapidTest Corp., expanding its portfolio with a PCR‑based stool assay and broadening distribution across Europe and Asia. Regulatory momentum accelerated as the FDA granted Breakthrough Device designation to a novel nanofluidic breath test, expediting market entry in the United States. Consumer preferences are shifting toward non‑invasive, home‑based kits, prompting manufacturers to launch smartphone‑integrated platforms that deliver results within 24 hours. Funding activity peaked when Heliotech Ventures led a $45 million Series C round for QuickDetect, earmarked for scaling manufacturing capacity and entering Latin American markets. Additionally, the EU’s revised In‑Vitro Diagnostic Regulation (IVDR) Phase III implementation, effective July 2024, is prompting firms to submit enhanced clinical performance data, accelerating validation pipelines across the continent.

Analyst Overview

Overall, the Helicobacter Pylori Detection Products market remains attractive due to rising prevalence of H. pylori infection and expanding screening programs in emerging economies. Competitive intensity is moderate; a handful of multinational diagnostics firms dominate, yet niche players are gaining share through point‑of‑care platforms and molecular assays. The long‑term Helicobacter Pylori Detection Products market outlook is positive, with CAGR projected above 7 % through 2032 as guidelines increasingly endorse non‑invasive testing. Innovation is concentrated on rapid antigen kits, PCR‑based multiplex panels, and AI‑enhanced result interpretation, creating a pipeline that can shorten turnaround time and improve sensitivity. Demand outpaces supply in regions where laboratory infrastructure is limited, prompting manufacturers to upscale production and form local partnerships. Key risk factors include regulatory delays, reimbursement uncertainty, and potential disruption from novel vaccine candidates that could reduce testing volume. Stakeholders should monitor policy shifts and invest in adaptable technologies to sustain growth. Geographically, Europe and North America retain premium pricing power, while Asia‑Pacific drives volume growth, prompting a wave of strategic M&A to secure distribution networks.

11 items

1. Executive Summary

2. Helicobacter Pylori Detection Products Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Helicobacter Pylori Detection Products Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Helicobacter Pylori Detection Products Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Medical

6.1.2. Experimental

6.1.3. Others

6.2. Global Helicobacter Pylori Detection Products Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Breath Test Products

6.2.2. Faecal Antigen Test Products

6.2.3. Serum Antibody Test Products

6.2.4. Other

6.3. Global Helicobacter Pylori Detection Products Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Helicobacter Pylori Detection Products Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Helicobacter Pylori Detection Products Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Helicobacter Pylori Detection Products Market Competition by Key Manufacturers

8.1. Global Helicobacter Pylori Detection Products Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Helicobacter Pylori Detection Products: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Thermo Scientific Chemicals

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Abbott

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Meridian

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. CTK Biotech

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Epitope Diagnostics

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Kibion

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. LKB-Wallac

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. KAMIYA Biomedical

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Abbexa

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Cordx Union

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. CLIAwaived

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Tri-Med

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Otsuka Holdings

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. MIZUHO MEDY

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. OPERON SA

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Sercon

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Fischer Analysen Instrumente

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. Shenzhen Zhonghe Headway

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. LabTech

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Helicobacter Pylori Detection Products Market

Figure 4: Global Helicobacter Pylori Detection Products Market: Drivers

Figure 5: Global Helicobacter Pylori Detection Products Market: Challenges

Figure 6: Global Helicobacter Pylori Detection Products Market: Trends

Figure 7: Global Helicobacter Pylori Detection Products Market: Opportunity

Figure 8: Global Helicobacter Pylori Detection Products Market: Restraint

Figure 9: Global Helicobacter Pylori Detection Products Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Helicobacter Pylori Detection Products Market Value (USD Million) By Region

Figure 15: Global Helicobacter Pylori Detection Products Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Helicobacter Pylori Detection Products Market Value (USD Million) By Region

Figure 23: Global Helicobacter Pylori Detection Products Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

91 items

Table 1: Market Segmentation Analysis

Table 2: Global Helicobacter Pylori Detection Products Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Helicobacter Pylori Detection Products Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Helicobacter Pylori Detection Products Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Helicobacter Pylori Detection Products Market Value (USD Million) By Region

Table 10: Global Helicobacter Pylori Detection Products Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Helicobacter Pylori Detection Products Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Helicobacter Pylori Detection Products Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Helicobacter Pylori Detection Products Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Thermo Scientific Chemicals Basic Information And Sales Area

Table 31: Thermo Scientific Chemicals. Products Portfolio

Table 32: Abbott Basic Information And Sales Area

Table 33: Abbott. Products Portfolio

Table 34: Meridian Basic Information And Sales Area

Table 35: Meridian. Products Portfolio

Table 36: CTK Biotech Basic Information And Sales Area

Table 37: CTK Biotech. Products Portfolio

Table 38: Epitope Diagnostics Basic Information And Sales Area

Table 39: Epitope Diagnostics. Products Portfolio

Table 40: Kibion Basic Information And Sales Area

Table 41: Kibion. Products Portfolio

Table 42: LKB-Wallac Basic Information And Sales Area

Table 43: LKB-Wallac. Products Portfolio

Table 44: KAMIYA Biomedical Basic Information And Sales Area

Table 45: KAMIYA Biomedical. Products Portfolio

Table 46: Abbexa Basic Information And Sales Area

Table 47: Abbexa. Products Portfolio

Table 48: Cordx Union Basic Information And Sales Area

Table 49: Cordx Union. Products Portfolio

Table 50: CLIAwaived Basic Information And Sales Area

Table 51: CLIAwaived. Products Portfolio

Table 52: Tri-Med Basic Information And Sales Area

Table 53: Tri-Med. Products Portfolio

Table 54: Otsuka Holdings Basic Information And Sales Area

Table 55: Otsuka Holdings. Products Portfolio

Table 56: MIZUHO MEDY Basic Information And Sales Area

Table 57: MIZUHO MEDY. Products Portfolio

Table 58: OPERON SA Basic Information And Sales Area

Table 59: OPERON SA. Products Portfolio

Table 60: Sercon Basic Information And Sales Area

Table 61: Sercon. Products Portfolio

Table 62: Fischer Analysen Instrumente Basic Information And Sales Area

Table 63: Fischer Analysen Instrumente. Products Portfolio

Table 64: Shenzhen Zhonghe Headway Basic Information And Sales Area

Table 65: Shenzhen Zhonghe Headway. Products Portfolio

Table 66: LabTech Basic Information And Sales Area

Table 67: LabTech. Products Portfolio

Table 68: Global Market Value (USD Million) (2025-2032) By Application

Table 69: Global Market Share (%) By Application (2032)

Table 70: Global Market Value (USD Million) (2025-2032) By Types

Table 71: Global Market Share (%) By Types (2032)

Table 72: Global Helicobacter Pylori Detection Products Market Value (USD Million) By Region

Table 73: Global Helicobacter Pylori Detection Products Market Share (%) By Region (2025-2032)

Table 74: North America Market Value (USD Million) (2025-2032) By Country

Table 75: North America Market Value (USD Million) (2025-2032) By Application

Table 76: North America Market Value (USD Million) (2025-2032) By Types

Table 77: Europe Market Value (USD Million) (2025-2032) By Country

Table 78: Europe Market Value (USD Million) (2025-2032) By Application

Table 79: Europe Market Value (USD Million) (2025-2032) By Types

Table 80: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 81: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 82: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 83: South America Market Value (USD Million) (2025-2032) By Country

Table 84: South America Market Value (USD Million) (2025-2032) By Application

Table 85: South America Market Value (USD Million) (2025-2032) By Types

Table 86: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 87: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 88: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 89: Research Programs/Design For This Report

Table 90: Key Data Information From Secondary Sources

Table 91: Key Data Information From Primary Sources

FAQs

1. What is the current Helicobacter Pylori Detection Products market size?

The Helicobacter Pylori Detection Products market size reached approximately USD 1.15 billion in 2023, reflecting strong demand for non‑invasive diagnostics across hospitals, clinics, and point‑of‑care settings worldwide. The growth is driven by rising prevalence of gastric infections, expanding screening programs, and increasing reimbursement coverage in major economies.

2. What is the projected growth rate and forecast for the market?

Forecasts predict the Helicobacter Pylori Detection Products market will expand at a compound annual growth rate of 5.8 % between 2024 and 2032, reaching roughly USD 1.85 billion by the end of the forecast horizon, supported by emerging economies and novel assay formats.

3. Which factors are driving the market’s expansion?

Key drivers include increasing incidence of H. pylori‑related ulcers, heightened awareness of gastric cancer risk, adoption of rapid immunoassays, and growing demand for at‑home testing kits, which collectively accelerate adoption across primary care and gastroenterology practices.

4. What challenges could hinder market growth?

Challenges arise from stringent validation requirements, limited reimbursement in low‑income regions, competition from molecular PCR platforms, and occasional false‑negative results due to antibiotic resistance, all of which may slow adoption and increase development costs for manufacturers.

5. Which regions currently lead the Helicobacter Pylori Detection Products market?

North America and Europe dominate the market, accounting for over 55 % of global revenue, while Asia‑Pacific shows the fastest CAGR, driven by large patient pools, rising middle‑class health spending, and government‑backed screening initiatives in China, India, and Japan.

6. Who are the top companies operating in this market?

Leading vendors include Abbott Laboratories, BioMérieux, Siemens Healthineers, Meridian Bioscience, and Luminex Corporation, each offering a portfolio of serology, stool antigen, and breath test kits that leverage proprietary antibodies or labeled substrates to improve diagnostic accuracy.

7. What future opportunities are emerging for the market?

Future outlook highlights opportunities in multiplex panels that combine H. pylori detection with other gastrointestinal pathogens, integration of AI‑driven result interpretation, expansion of tele‑medicine distribution channels, and partnerships with pharmaceutical firms developing eradication therapies to create bundled diagnostic‑therapeutic packages for clinicians.

8. How is technology influencing product development?

Advances in microfluidics, recombinant antigen engineering, and digital readout platforms enable faster turnaround times, higher sensitivity, and seamless integration with electronic health records, positioning next‑generation kits as essential tools for point‑of‑care and remote diagnostics globally.

9. What is the regulatory landscape for these products?

Regulatory pathways differ by region; in the U.S., devices must obtain FDA 510(k) clearance, while Europe requires CE marking under IVDR, and Asian markets often follow local health ministry approvals. Compliance demands rigorous clinical validation and post‑market surveillance.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Helicobacter Pylori Detection Products Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.12 billion
Growth rate	CAGR of 7.4% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Scientific Chemicals; Abbott; Meridian; CTK Biotech; Epitope Diagnostics; Kibion; LKB-Wallac; KAMIYA Biomedical; Abbexa; Cordx Union; CLIAwaived; Tri-Med; Otsuka Holdings; MIZUHO MEDY; OPERON SA; Sercon; Fischer Analysen Instrumente; Shenzhen Zhonghe Headway; LabTech
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options